Dent Neurologic

Pediatric Neurology Center

Mohammad M. Qasaymeh, MD, MS

Center Director

Research Trial Information

“Learn more about The AbbVie PERISCOPE Study (also known as the 3110-305-002 Study), evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.”

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top